Finance

Lists
Q2 2027 earnings • released • EPS miss -14.34% • Revenue beat +0.36%
See results
PHR:NYSE
Phreesia Inc
$11.10
0.00%
(0.00) 1D
$11.10
0.00% (0.00)
Pre-market
Closed: Sep 3, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHR...
Mkt. cap
686.11M
Avg. vol.
795.71K
Volume
779.00
P/E ratio
65.72
52-wk high
$30.43
52-wk low
$7.77
EPS
$0.17
Beta
0.86
Shares outstanding
61.81M
No. of employees
2K
Mkt. cap
686.11M
Avg. vol.
795.71K
Volume
779.00
P/E ratio
65.72
52-wk high
$30.43
52-wk low
$7.77
EPS
$0.17
Beta
0.86
Shares outstanding
61.81M
No. of employees
2K
News stories
From web sources and news partners
Profile
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake. Wikipedia
About Phreesia Inc
CEOChaim Indig
Employees1.79K
Founded2005
HeadquartersWilmington, Delaware, United States
SectorHealth care
Websitephreesia.com
Analyst ratings
Based on 11 analysts giving stock ratings to PHR in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PHR in the last 3 months.
Highest
Current $11.10
$19.00 (+71.17%)
Average
$13.44 (+21.08%)
Lowest
$10.00 (-9.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Vruwink
Robert W. Baird
Hold
Maintained
$11.00
-0.9%
09/04/2026
Clark Wright
D.A. Davidson
Buy
Maintained
$13.00
+17.1%
09/04/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/03/2026
Ryan Halsted
RBC Capital
Buy
Maintained
$19.00
+71.2%
09/03/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$16.00
+44.1%
09/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Reiterated
$10.00
-9.9%
09/03/2026
Ryan MacDonald
Needham
Buy
Reiterated
$14.00
+26.1%
09/03/2026
Glen Santangelo
Barclays
Hold
Maintained
$10.00
-9.9%
09/03/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
09/02/2026
Alexei Gogolev
J.P. Morgan
Hold
Reiterated
$14.00
+26.1%
06/25/2026
Sean Dodge
BMO Capital
Buy
Maintained
$14.00
+26.1%
06/22/2026
Jessica Tassan
Piper Sandler
Hold
Downgraded
$12.00
+8.1%
05/28/2026
Unknown Analyst
Jefferies
Buy
Maintained
$20.00
+80.2%
05/28/2026
Dan Waggoner
D.A. Davidson
Buy
Maintained
$14.00
+26.1%
05/28/2026
Daniel Grosslight
Citi
Hold
Reiterated
$12.00
+8.1%
05/28/2026
Unknown Analyst
KeyBanc
Buy
Reiterated
$12.00
+8.1%
04/13/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
$12.00
+8.1%
04/13/2026
Aaron Kimson
Citizens JMP
Hold
Downgraded
-
-
04/01/2026
Jeffrey Garro
Stephens
Buy
Maintained
$20.00
+80.2%
03/31/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$19.00
+71.2%
03/24/2026
Last report
Sep 2, 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
$0.28 / $0.32
-14.34%miss
Revenue / Est. (USD)
129.46M / 128.99M
+0.36%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
117.26M
120.33M
127.07M
130.94M
Cost of goods sold
37.64M
38.03M
40.39M
43.33M
Cost of revenue
37.64M
38.03M
40.39M
43.33M
Research and development expenses
29.27M
29.45M
30.92M
28.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.44M
39.66M
44.37M
42.57M
Operating expense
81.12M
76.59M
84.98M
80.85M
Total operating expenses
118.76M
114.62M
125.37M
124.19M
Operating income
-1.51M
5.71M
1.69M
6.75M
Other non operating income
336.00K
1.01M
1.27M
-7.00K
EBT including unusual items
-563.00K
5.12M
-10.32M
4.72M
EBT excluding unusual items
-563.00K
7.10M
-2.57M
4.74M
Income tax expense
-1.22M
854.00K
-11.62M
1.76M
Effective tax rate
216.16%
16.66%
112.54%
37.26%
Other operating expenses
-
-
-
-
Net income
654.00K
4.27M
1.30M
2.96M
Net profit margin
0.56%
3.55%
1.02%
2.26%
Earnings per share
0.27
0.31
0.44
0.27
Interest and investment income
999.00K
700.00K
269.00K
297.00K
Interest expense
-391.00K
-320.00K
-5.81M
-2.30M
Net interest expenses
608.00K
380.00K
-5.54M
-2.00M
Depreciation and amortization charges
3.28M
3.20M
3.51M
3.37M
EBITDA
2.64M
13.19M
7.67M
12.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps